NANOBIOTIX enters ultimate contract negotiations following settlement on a non-binding time period sheet for the event and commercialization of NBTXR3 with a serious world pharmaceutical firm
Nanobiotix SA The corporate accepted the time period sheet as of Might 3, 2023 PARIS and CAMBRIDGE, Mass., Might 05, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO NASDAQ: NBTX on …
NANOBIOTIX enters ultimate contract negotiations following settlement on a non-binding time period sheet for the event and commercialization of NBTXR3 with a serious world pharmaceutical firm Read More